Previous Page  825 / 827 Next Page
Information
Show Menu
Previous Page 825 / 827 Next Page
Page Background

865

T-bet expressing B cells are required for thedevelopment of

autoimmunity

Kira Rubtsova

1,2

, Anatoly V. Rubtsov

1,2

, John W. Kappler

1,2,3,5

and

Philippa Marrack

1,2,4,5

1

Howard Hughes Medical Institute, Denver, CO,80206.

2

Department of Immunology, National Jewish Health and University

of ColoradoHealth Sciences Center, Denver, CO 80206, USA.

4

Department of Pharmacology, University of Colorado School of

Medicine, Aurora,CO 80045, USA.

5

Department of Medicine, University of Colorado School of Medicine,

Aurora, CO80045, USA.

6

Department of Biochemistry and Molecular Genetics, University of

ColoradoHealth Sciences Center, Aurora, CO 80045, USA.

Autoimmune diseases are common, affecting about 8% of the

population of the USA. Since there is no cure for autoimmunity, it

is extremely important to study the mechanisms that trigger these

diseases.Themajority of autoimmune diseasesaffect predominantly

females more than males, indicating a strong gender bias.

We have recently identified a subset of B cells that accumulates in

aged female mice and can be characterized by the expression of

CD11c and the transcription factor,T- bet. A related subset is found

in autoimmune mice, appearing at the onset of the disease. T-bet+

B cells obtained from autoimmune mice produce high levels of

auto- antibodies upon stimulation. Expression of T-bet in B cells is

necessary andsufficient for the appearance these cells.

These data led us to hypothesize that T-bet expressing B cells are

major precursors of autoantibody producing B cells during the

autoimmune response. Therefore ablationof this subset should lead

to the ablation of or significant delay in the onset of autoimmunity.

In this study we explored the role of T-bet expressing B cells in the

appearance of autoantibodies in SLE1,2,3 mice, a model of lupus.

We have generated mice thatlack

T-bet expression only in B cells by crossing (SLE1,2,3 x T-bet

flox/flox

x CD19

CRE

) animals We followed the appearance of autoantibodies

in these mice, comparing them to (SLE1,2,3 xT-bet

flox/flox

) littermate

controls. Our data indicate that kidney function and survival is

significantly improved in (SLE1,2,3 xT-bet

flox/flox

x CD19

CRE

)mice. At the

same time the titers of autoantibodies were dramatically decreased

in the (SLE1,2,3xT- bet

flox/flox

xCD19

CRE

) mice when compared to

littermate controls. Analysis of the T and B cell compartments

revealed a reduction of germinal cente B cells, pre-plasmablasts,

activated/memory T cells and IFNγ producing T cells. These data

indicate that T-bet expression in B cells plays an important role

during the onset of lupus-like

autoimmunity. Moreover, T-bet expression in B cells was not

required for the development of germinal centers and production

of antibodies in response to vaccination, suggesting that T-bet in B

cells can serve as a novel target for the treatment of autoimmunity

without dramatic impact on the other aspects ofimmune system.

In conclusion our data suggest that T-bet expression in B cells is

required for the generation of autoimmune responses, appearance

of pathogenic autoantibodies and destruction of kidney function.

Therefore conditional deletion of T-bet from B cells leads to the

overall improvement in autoimmune-pronemice.

A high throughput method to characterize monoclonal

antibodies and select native antigen specific IgG hybridoma

cells

Haolin Liu

1

,Janice White

1

,Frances Crawford

1,2

,Gongyi Zhang

1

,Philippa

Marrack

1,2

and John W.Kappler

1,2

1

Department of Biomedical Research, National Jewish Health, Denver,

CO 80206 and

2

Howard Hughes Medical Institute

B cell hybridomas are important source of monoclonal antibodies.

However, the traditional method of using antigen-coated ELISA

plate to detect antibody secretion and using limiting dilution to

select hybridoma cells is time and labor consuming. Moreover,

antigen coated ELISA can’t distinguish antibodies against

the native and denature antigen. To solve these problems, we

developed a high throughput method to characterize mouse IgG

antibodies using Surface Plasmon Resonance (SPR) technology.

This assay rapidly determines their sub-isotypes, whether they bind

native antigen and their approximate affinities for the antigen with

only microliters of hybridoma cell culture supernatant. It could be

used to find out pairs of antibodies that can be used as coating

and detecting antibodies for commercial ELISA kit and blocking

antibodies of virus entry into host. Meanwhile, we found that

mouse hybridomas secreting IgG antibodies also have membrane

form IgG expression. Based on this surface IgG, we isolated rare

γ2a isotype switched variants from a γ2b antibody secreting

hybridoma cell line. We also used fluorescent antigen to single

cell sort native antigen binding hybridoma cells from bulk fusion

mixture thus saving time and labor.